Acasti Pharma (ACST)
(Delayed Data from NSDQ)
$2.90 USD
-0.03 (-0.97%)
Updated Apr 26, 2024 02:27 PM ET
After-Market: $2.92 +0.02 (0.69%) 7:58 PM ET
3-Hold of 5 3
F Value A Growth C Momentum C VGM
Key Expected Earnings Data
Report Date | Period Ending | Zacks Consensus Estimate | Earnings ESP |
---|---|---|---|
06/28/2024
Time: -- |
3/2024 | $-0.35 | 0.00% |
Earnings Summary
For their last quarter, Acasti Pharma (ACST) reported earnings of -$0.21 per share, beating the Zacks Consensus Estimate of $-0.30 per share. This reflects a positive earnings surprise of 30.00%. Look out for ACST's next earnings release expected on June 28, 2024. For the next earning release, we expect the company to report earnings of -$0.35 per share, reflecting a year-over-year decrease of 16.67%.
Earnings History
Price & Consensus
Zacks News for ACST
TEVA to Pay $225 Million to Settle Price-Fixing Charges (Revised)
ACST: What are Zacks experts saying now?
Zacks Private Portfolio Services